Compounds 5a–c were further investigated on the PDK1/Akt pathway, and only 5a (Chart 2) was shown to inhibit PDK1 kinase and also other downstream effectors essential for GBM-derived stem cell survival. The gene discussed is PDK1; the disease is glioblastoma.